James P. O’Connell

3.3k total citations
36 papers, 2.6k citations indexed

About

James P. O’Connell is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, James P. O’Connell has authored 36 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in James P. O’Connell's work include Protease and Inhibitor Mechanisms (12 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Peptidase Inhibition and Analysis (7 papers). James P. O’Connell is often cited by papers focused on Protease and Inhibitor Mechanisms (12 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Peptidase Inhibition and Analysis (7 papers). James P. O’Connell collaborates with scholars based in United Kingdom, United States and Canada. James P. O’Connell's co-authors include Andrew Docherty, Gillian Murphy, Frances Willenbrock, William F. Butler, Michael J. Heller, Eugene Tu, Thomas Crabbe, Edward L. Sheldon, Lei Wu and Michael J. Heller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

James P. O’Connell

35 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James P. O’Connell United Kingdom 25 1.1k 1.0k 652 553 417 36 2.6k
Michael Etzerodt Denmark 30 1.6k 1.5× 703 0.7× 252 0.4× 205 0.4× 364 0.9× 69 2.8k
Partha Ray United States 20 1.5k 1.4× 381 0.4× 387 0.6× 222 0.4× 128 0.3× 49 2.3k
Catherine Grillon France 21 773 0.7× 445 0.4× 282 0.4× 297 0.5× 59 0.1× 55 2.2k
Walker Wharton United States 27 1.9k 1.8× 311 0.3× 921 1.4× 250 0.5× 365 0.9× 74 3.5k
Þórarinn Guðjónsson Iceland 30 1.6k 1.5× 706 0.7× 1.7k 2.7× 348 0.6× 36 0.1× 78 3.4k
Young Song United States 28 2.6k 2.4× 671 0.7× 728 1.1× 194 0.4× 137 0.3× 56 3.9k
Roberta Di Pietro Italy 24 985 0.9× 274 0.3× 289 0.4× 219 0.4× 87 0.2× 101 1.9k
Kenji Yokoi United States 29 1.5k 1.4× 456 0.5× 730 1.1× 624 1.1× 51 0.1× 90 2.8k
Stephen R. Pennington Ireland 31 1.5k 1.4× 273 0.3× 295 0.5× 244 0.4× 241 0.6× 133 3.0k
M. Hinz Germany 26 1.9k 1.7× 1.1k 1.1× 829 1.3× 177 0.3× 109 0.3× 95 3.6k

Countries citing papers authored by James P. O’Connell

Since Specialization
Citations

This map shows the geographic impact of James P. O’Connell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. O’Connell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. O’Connell more than expected).

Fields of papers citing papers by James P. O’Connell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. O’Connell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. O’Connell. The network helps show where James P. O’Connell may publish in the future.

Co-authorship network of co-authors of James P. O’Connell

This figure shows the co-authorship network connecting the top 25 collaborators of James P. O’Connell. A scholar is included among the top collaborators of James P. O’Connell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. O’Connell. James P. O’Connell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Connell, James P., et al.. (2024). Glasgow-Blatchford and Rockall score utility in predicting findings on video capsule endoscopy in patients admitted with overt small bowel bleeding. SHILAP Revista de lepidopterología. 13(CP). a24521219–a24521219.
2.
Lightwood, Daniel, John Porter, David McMillan, et al.. (2021). A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF. Nature Communications. 12(1). 583–583. 22 indexed citations
3.
McMillan, David, C. Martinez-Fleites, John Porter, et al.. (2021). Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF. Nature Communications. 12(1). 582–582. 63 indexed citations
4.
O’Connell, James P., John Porter, Stephen Rapecki, et al.. (2019). Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer. Nature Communications. 10(1). 5795–5795. 81 indexed citations
5.
Burgos, Pierre, Anthony W. Parker, Valentina Iadevaia, et al.. (2013). mTOR direct interactions with Rheb-GTPase and raptor: sub-cellular localization using fluorescence lifetime imaging. BMC Cell Biology. 14(1). 3–3. 55 indexed citations
6.
O’Connell, James P., et al.. (2007). Minimizing Tolerance and Withdrawal to Prolonged Pediatric Sedation: Case Report and Review of the Literature. Journal of Intensive Care Medicine. 22(3). 173–179. 26 indexed citations
7.
Moffat, D., Rodger A. Allen, Stephen Rapecki, et al.. (2004). 4-Thiophenoxy-N-(3,4,5-Trialkoxyphenyl)Pyrimidine-2-Amines as Potent and Selective Inhibitors of the T-Cell Tyrosine Kinase p56lck. Current Medicinal Chemistry. 11(6). 747–753. 2 indexed citations
8.
Moffat, David, Peter D. Davis, Jeremy Davis, et al.. (1999). 4-Pyridin-5-yl-2-(3,4,5-trimethoxyphenylamino)pyrimidines: Potent and selective inhibitors of ZAP 70. Bioorganic & Medicinal Chemistry Letters. 9(23). 3351–3356. 14 indexed citations
9.
Cheng, Jing, Edward L. Sheldon, Lei Wu, et al.. (1998). Preparation and hybridization analysis of DNA/RNA from E. coli on microfabricated bioelectronic chips. Nature Biotechnology. 16(6). 541–546. 253 indexed citations
10.
Perry, Maria de Jesus, James P. O’Connell, Christoph Walker, et al.. (1998). CDP840. Cell Biochemistry and Biophysics. 29(1-2). 113–132. 23 indexed citations
11.
Cheng, Jing, Edward L. Sheldon, Lei Wu, Michael J. Heller, & James P. O’Connell. (1998). Isolation of Cultured Cervical Carcinoma Cells Mixed with Peripheral Blood Cells on a Bioelectronic Chip. Analytical Chemistry. 70(11). 2321–2326. 126 indexed citations
12.
Tu, Eugene, et al.. (1997). Rapid determination of single base mismatch mutations in DNA hybrids by direct electric field control. Proceedings of the National Academy of Sciences. 94(4). 1119–1123. 362 indexed citations
13.
Frears, Emma R., et al.. (1996). Inactivation of tissue inhibitor of metalloproteinase‐1 by peroxynitrite. FEBS Letters. 381(1-2). 21–24. 141 indexed citations
14.
Chander, Surinder K., Pari Antoniw, Nigel R. A. Beeley, et al.. (1995). An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase A. Journal of Pharmaceutical Sciences. 84(4). 404–409. 10 indexed citations
15.
Crabbe, Thomas, James P. O’Connell, Bryan John Smith, & Andrew Docherty. (1994). Reciprocated matrix metalloproteinase activation: A process performed by interstitial collagenase and progelatinase A. Biochemistry. 33(48). 14419–14425. 82 indexed citations
16.
Crabbe, Thomas, Stanley Zucker, Mark I. Cockett, et al.. (1994). Mutation of the Active Site Glutamic Acid of Human Gelatinase A: Effects on Latency, Catalysis, and the Binding of Tissue Inhibitor of Metalloproteinases-1. Biochemistry. 33(21). 6684–6690. 59 indexed citations
17.
O’Connell, James P., et al.. (1994). Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B.. Journal of Biological Chemistry. 269(21). 14967–14973. 135 indexed citations
18.
Crabbe, Thomas, Bryan Ronain Smith, James P. O’Connell, & Andrew Docherty. (1994). Human progelatinase A can be activated by matrilysin. FEBS Letters. 345(1). 14–16. 82 indexed citations
19.
Porter, John, Nigel R. A. Beeley, Byron A. Boyce, et al.. (1994). Potent and selective inhibitors of gelatinase-a 1. hydroxamic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 4(23). 2741–2746. 33 indexed citations
20.
Docherty, Andrew, James P. O’Connell, Tom Crabbe, Sarojani Angal, & Gillian Murphy. (1992). The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends in biotechnology. 10(6). 200–207. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Etzerodt Breakdown of academic impact, for papers by Partha Ray Breakdown of academic impact, for papers by Catherine Grillon Breakdown of academic impact, for papers by Walker Wharton Breakdown of academic impact, for papers by Þórarinn Guðjónsson Breakdown of academic impact, for papers by Young Song Breakdown of academic impact, for papers by Roberta Di Pietro Breakdown of academic impact, for papers by Kenji Yokoi Breakdown of academic impact, for papers by Stephen R. Pennington Breakdown of academic impact, for papers by M. Hinz
Rankless by CCL
2026